(Q33681951)

28 July 2017

title

Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study (English)

1 reference

28 July 2017

1 reference

I Ahmed

1

0 references

author name string

F Thiessard

2

1 reference

28 July 2017

G Miremont-Salamé

3

1 reference

28 July 2017

B Bégaud

4

1 reference

28 July 2017

P Tubert-Bitter

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Clinical Pharmacology & Therapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

88

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

492-498

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2010.111

28 July 2017

exact match

0 references

cites work

A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

A Bayesian neural network method for adverse drug reaction signal generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

False discovery rate estimation for frequentist pharmacovigilance signal detection methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Decision support methods for the detection of adverse events in post-marketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

The effect of backgrounds in safety analysis: the impact of comparison cases on what you see

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

The role of data mining in pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Novel statistical tools for monitoring the safety of marketed drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Perspectives on the use of data mining in pharmaco-vigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

A new drug classification for computer systems: the ATC extension code.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

The medical dictionary for regulatory activities (MedDRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

Power and weakness of spontaneous reporting: a probabilistic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.111

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.111

1 reference

Dimensions Publication ID

28 July 2017

1001564711

0 references

1 reference